

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.63818593 |
| 2 | protein retention in ER lumen (GO:0006621) | 7.14402573 |
| 3 | signal peptide processing (GO:0006465) | 6.98791136 |
| 4 | COPII vesicle coating (GO:0048208) | 6.12085835 |
| 5 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.89104409 |
| 6 | protein maturation by protein folding (GO:0022417) | 5.80794257 |
| 7 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.74781042 |
| 8 | exocrine pancreas development (GO:0031017) | 5.69417819 |
| 9 | positive regulation of nuclease activity (GO:0032075) | 5.53533007 |
| 10 | regulation of nuclease activity (GO:0032069) | 5.05186800 |
| 11 | endoplasmic reticulum unfolded protein response (GO:0030968) | 5.00994283 |
| 12 | cellular response to unfolded protein (GO:0034620) | 4.85483264 |
| 13 | cellular response to topologically incorrect protein (GO:0035967) | 4.77879265 |
| 14 | ER-nucleus signaling pathway (GO:0006984) | 4.51398360 |
| 15 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.49621710 |
| 16 | sequestering of metal ion (GO:0051238) | 4.47961613 |
| 17 | endocrine pancreas development (GO:0031018) | 4.32543414 |
| 18 | * protein N-linked glycosylation via asparagine (GO:0018279) | 4.28866984 |
| 19 | vesicle coating (GO:0006901) | 4.26049463 |
| 20 | * peptidyl-asparagine modification (GO:0018196) | 4.24718311 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 4.10254424 |
| 22 | response to endoplasmic reticulum stress (GO:0034976) | 4.06460282 |
| 23 | * protein N-linked glycosylation (GO:0006487) | 3.93029081 |
| 24 | proline biosynthetic process (GO:0006561) | 3.92539615 |
| 25 | 4-hydroxyproline metabolic process (GO:0019471) | 3.87583748 |
| 26 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.86587063 |
| 27 | peptide hormone processing (GO:0016486) | 3.85508645 |
| 28 | response to unfolded protein (GO:0006986) | 3.80426451 |
| 29 | response to topologically incorrect protein (GO:0035966) | 3.74443716 |
| 30 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.72107438 |
| 31 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.67223076 |
| 32 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.62779595 |
| 33 | pinocytosis (GO:0006907) | 3.57618980 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56868578 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56868578 |
| 36 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.47607946 |
| 37 | glandular epithelial cell differentiation (GO:0002067) | 3.44907230 |
| 38 | peptide catabolic process (GO:0043171) | 3.43503182 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.40303201 |
| 40 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.35391862 |
| 41 | protein targeting to ER (GO:0045047) | 3.31336168 |
| 42 | cotranslational protein targeting to membrane (GO:0006613) | 3.26933744 |
| 43 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.17681752 |
| 44 | protein localization to endoplasmic reticulum (GO:0070972) | 3.16737843 |
| 45 | tricarboxylic acid metabolic process (GO:0072350) | 3.16680686 |
| 46 | galactose catabolic process (GO:0019388) | 3.07261040 |
| 47 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.05071521 |
| 48 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05067772 |
| 49 | valine metabolic process (GO:0006573) | 3.01997148 |
| 50 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.01537766 |
| 51 | * GDP-mannose metabolic process (GO:0019673) | 2.98697392 |
| 52 | cell redox homeostasis (GO:0045454) | 2.97964013 |
| 53 | purine nucleotide salvage (GO:0032261) | 2.93398338 |
| 54 | intestinal absorption (GO:0050892) | 2.89601738 |
| 55 | mannose metabolic process (GO:0006013) | 2.89020920 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87041986 |
| 57 | peptidyl-proline hydroxylation (GO:0019511) | 2.86303830 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.84996944 |
| 59 | protein carboxylation (GO:0018214) | 2.84996944 |
| 60 | adhesion of symbiont to host (GO:0044406) | 2.84557672 |
| 61 | digestion (GO:0007586) | 2.84463500 |
| 62 | barbed-end actin filament capping (GO:0051016) | 2.83939698 |
| 63 | positive regulation of insulin secretion (GO:0032024) | 2.83125449 |
| 64 | ER overload response (GO:0006983) | 2.81705339 |
| 65 | mitochondrial calcium ion transport (GO:0006851) | 2.76628133 |
| 66 | L-phenylalanine catabolic process (GO:0006559) | 2.75878362 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.75878362 |
| 68 | response to misfolded protein (GO:0051788) | 2.75728594 |
| 69 | nucleoside diphosphate catabolic process (GO:0009134) | 2.74467598 |
| 70 | keratan sulfate catabolic process (GO:0042340) | 2.73057729 |
| 71 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71962478 |
| 72 | pentose-phosphate shunt (GO:0006098) | 2.71848693 |
| 73 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70616233 |
| 74 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70086168 |
| 75 | protein autoprocessing (GO:0016540) | 2.69602271 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 2.68783329 |
| 77 | virion attachment to host cell (GO:0019062) | 2.68783329 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.68383665 |
| 79 | L-phenylalanine metabolic process (GO:0006558) | 2.68383665 |
| 80 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.68261635 |
| 81 | pentose metabolic process (GO:0019321) | 2.66400361 |
| 82 | fucose metabolic process (GO:0006004) | 2.66374694 |
| 83 | cellular response to vitamin D (GO:0071305) | 2.66086633 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 2.64379525 |
| 85 | regulation of extracellular matrix disassembly (GO:0010715) | 2.64331849 |
| 86 | glycosphingolipid catabolic process (GO:0046479) | 2.62679549 |
| 87 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.62629574 |
| 88 | proline metabolic process (GO:0006560) | 2.62005749 |
| 89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62000279 |
| 90 | positive regulation of extracellular matrix organization (GO:1903055) | 2.61894688 |
| 91 | regulation of superoxide anion generation (GO:0032928) | 2.61502519 |
| 92 | regulation of metalloenzyme activity (GO:0048552) | 2.60859592 |
| 93 | glucose 6-phosphate metabolic process (GO:0051156) | 2.60389208 |
| 94 | Golgi organization (GO:0007030) | 2.59527002 |
| 95 | skin morphogenesis (GO:0043589) | 2.57718376 |
| 96 | oxaloacetate metabolic process (GO:0006107) | 2.57686806 |
| 97 | peptide metabolic process (GO:0006518) | 2.56637107 |
| 98 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.56613739 |
| 99 | glycolipid catabolic process (GO:0019377) | 2.56513725 |
| 100 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.55479523 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.54692410 |
| 102 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.54692410 |
| 103 | regulation of cholesterol esterification (GO:0010872) | 2.54611809 |
| 104 | UV protection (GO:0009650) | 2.54184019 |
| 105 | hyaluronan catabolic process (GO:0030214) | 2.54054312 |
| 106 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.52844902 |
| 107 | nucleotide salvage (GO:0043173) | 2.52263745 |
| 108 | amino sugar catabolic process (GO:0046348) | 2.52194838 |
| 109 | * nucleotide-sugar metabolic process (GO:0009225) | 2.51783445 |
| 110 | glycoside metabolic process (GO:0016137) | 2.51669425 |
| 111 | maintenance of protein localization in organelle (GO:0072595) | 2.51633848 |
| 112 | toxin metabolic process (GO:0009404) | 2.51461808 |
| 113 | NIK/NF-kappaB signaling (GO:0038061) | 2.50609626 |
| 114 | protein-lipid complex assembly (GO:0065005) | 2.50327956 |
| 115 | NADPH regeneration (GO:0006740) | 2.50168025 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.49255793 |
| 117 | type B pancreatic cell development (GO:0003323) | 2.48386367 |
| 118 | glucose catabolic process (GO:0006007) | 2.46900048 |
| 119 | epithelial cell fate commitment (GO:0072148) | 2.46578971 |
| 120 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.46423769 |
| 121 | glandular epithelial cell development (GO:0002068) | 2.45536926 |
| 122 | protein localization to endosome (GO:0036010) | 2.43489961 |
| 123 | DNA deamination (GO:0045006) | 2.41896178 |
| 124 | endosome to pigment granule transport (GO:0043485) | 2.40050597 |
| 125 | endosome to melanosome transport (GO:0035646) | 2.40050597 |
| 126 | purine-containing compound salvage (GO:0043101) | 2.40038030 |
| 127 | ribosomal small subunit assembly (GO:0000028) | 2.39956163 |
| 128 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.39169851 |
| 129 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.38764481 |
| 130 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36637397 |
| 131 | NADH metabolic process (GO:0006734) | 2.36572836 |
| 132 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.36357455 |
| 133 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.36023166 |
| 134 | negative regulation of cell size (GO:0045792) | 2.33882230 |
| 135 | beta-amyloid metabolic process (GO:0050435) | 2.33036961 |
| 136 | negative regulation of fibrinolysis (GO:0051918) | 2.31483650 |
| 137 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.30897252 |
| 138 | sphingolipid catabolic process (GO:0030149) | 2.30842356 |
| 139 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.30721811 |
| 140 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.28749052 |
| 141 | pyrimidine nucleoside salvage (GO:0043097) | 2.27228565 |
| 142 | pyrimidine-containing compound salvage (GO:0008655) | 2.27228565 |
| 143 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.26065453 |
| 144 | membrane lipid catabolic process (GO:0046466) | 2.25932522 |
| 145 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.25814687 |
| 146 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.25665554 |
| 147 | regulation of plasminogen activation (GO:0010755) | 2.25244571 |
| 148 | amyloid precursor protein catabolic process (GO:0042987) | 2.23867791 |
| 149 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.23459402 |
| 150 | ceramide catabolic process (GO:0046514) | 2.22303117 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.22265896 |
| 152 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.21786050 |
| 153 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.20815585 |
| 154 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.18394607 |
| 155 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.18300277 |
| 156 | negative regulation of viral release from host cell (GO:1902187) | 2.18287841 |
| 157 | myeloid dendritic cell differentiation (GO:0043011) | 2.18071018 |
| 158 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.17456252 |
| 159 | mature B cell differentiation involved in immune response (GO:0002313) | 2.16387319 |
| 160 | * nucleotide-sugar biosynthetic process (GO:0009226) | 2.15936316 |
| 161 | regulation of cholesterol homeostasis (GO:2000188) | 2.14640792 |
| 162 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.14367410 |
| 163 | urea cycle (GO:0000050) | 2.13862092 |
| 164 | lipopolysaccharide metabolic process (GO:0008653) | 2.12555290 |
| 165 | protein hydroxylation (GO:0018126) | 2.11301974 |
| 166 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.09526313 |
| 167 | response to thyroid hormone (GO:0097066) | 2.09259606 |
| 168 | basement membrane organization (GO:0071711) | 2.08560832 |
| 169 | regulation of fibrinolysis (GO:0051917) | 2.08302591 |
| 170 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.07722290 |
| 171 | Golgi transport vesicle coating (GO:0048200) | 10.1661404 |
| 172 | COPI coating of Golgi vesicle (GO:0048205) | 10.1661404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03589868 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.96967904 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64554821 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.58728153 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.49761117 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.47554467 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47534765 |
| 8 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.45073301 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.25335919 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.23412851 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.21863395 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.18297535 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.16071034 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14714466 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13069588 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.07534021 |
| 17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04748631 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00107238 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.97698319 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95270991 |
| 21 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83326058 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.79052735 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78714543 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76957363 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76307087 |
| 26 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73376261 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73263698 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71870766 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.70943926 |
| 30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.70448593 |
| 31 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.69805067 |
| 32 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.69394240 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62448599 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59823171 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57882190 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56720305 |
| 37 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.56286587 |
| 38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.54650243 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54476178 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53448917 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52430280 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51246168 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.51051005 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.48107900 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47673983 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46054235 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45283108 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44903848 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44498322 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42772065 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39867691 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.39606860 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38928780 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38672429 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38158751 |
| 56 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.37397283 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35467585 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35018094 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.34772624 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33939176 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32013625 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30346361 |
| 63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29924222 |
| 64 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29825498 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29470686 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 1.28642202 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.27932351 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.25947004 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24875127 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23734305 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23708855 |
| 72 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23572061 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23239585 |
| 74 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.22987540 |
| 75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22099987 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22071104 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22049484 |
| 78 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21881066 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20940958 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20576670 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20544383 |
| 82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20247914 |
| 83 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20134852 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.19259140 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18878072 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18668493 |
| 87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18437097 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.17752822 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17056204 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16708360 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16517566 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15477980 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15397915 |
| 94 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15366311 |
| 95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15353543 |
| 96 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14850136 |
| 97 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.14450745 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14145661 |
| 99 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.13586492 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13561453 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13230807 |
| 102 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.13123934 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12896620 |
| 104 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12375655 |
| 105 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.10019968 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09812948 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09580579 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09522717 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09361030 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09046196 |
| 111 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08887901 |
| 112 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08768648 |
| 113 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08548342 |
| 114 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08044259 |
| 115 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07796422 |
| 116 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.07716426 |
| 117 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07624315 |
| 118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06510785 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05969316 |
| 120 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05960465 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05618261 |
| 122 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05311743 |
| 123 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03886305 |
| 124 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03742899 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03644868 |
| 126 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03551292 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03531224 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03205664 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03062893 |
| 130 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02912362 |
| 131 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02466039 |
| 132 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02060632 |
| 133 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01318226 |
| 134 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00766712 |
| 135 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00718409 |
| 136 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00632407 |
| 137 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99819874 |
| 138 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99692957 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99200419 |
| 140 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99099155 |
| 141 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98450952 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97704558 |
| 143 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97189146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005220_abnormal_exocrine_pancreas | 3.37266733 |
| 2 | MP0005451_abnormal_body_composition | 3.29880421 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.15500750 |
| 4 | MP0001666_abnormal_nutrient_absorption | 3.09180075 |
| 5 | MP0002693_abnormal_pancreas_physiology | 3.05869469 |
| 6 | MP0003183_abnormal_peptide_metabolism | 2.98588832 |
| 7 | MP0005365_abnormal_bile_salt | 2.84800599 |
| 8 | MP0003195_calcinosis | 2.80599153 |
| 9 | MP0001944_abnormal_pancreas_morphology | 2.69882852 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.61892499 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.56084103 |
| 12 | MP0003283_abnormal_digestive_organ | 2.53698885 |
| 13 | MP0004043_abnormal_pH_regulation | 2.45074248 |
| 14 | MP0005083_abnormal_biliary_tract | 2.43015132 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.31228805 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 2.26607984 |
| 17 | MP0006054_spinal_hemorrhage | 2.22487961 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.16592418 |
| 19 | MP0010386_abnormal_urinary_bladder | 2.15137406 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.12907053 |
| 21 | MP0008260_abnormal_autophagy | 2.08531164 |
| 22 | MP0000678_abnormal_parathyroid_gland | 1.98821194 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.94932671 |
| 24 | MP0009840_abnormal_foam_cell | 1.90347415 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.89220572 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.83384743 |
| 27 | MP0003868_abnormal_feces_composition | 1.81844701 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.79795463 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.78063707 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.68132000 |
| 31 | MP0002078_abnormal_glucose_homeostasis | 1.66993068 |
| 32 | MP0003436_decreased_susceptibility_to | 1.66465517 |
| 33 | MP0003866_abnormal_defecation | 1.59786916 |
| 34 | MP0003279_aneurysm | 1.57935053 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.51467770 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.50193030 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.48312955 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.44832020 |
| 39 | MP0000685_abnormal_immune_system | 1.43740106 |
| 40 | MP0008438_abnormal_cutaneous_collagen | 1.41469575 |
| 41 | MP0004272_abnormal_basement_membrane | 1.38103132 |
| 42 | MP0003959_abnormal_lean_body | 1.36820769 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.36381810 |
| 44 | MP0003186_abnormal_redox_activity | 1.36117484 |
| 45 | MP0003252_abnormal_bile_duct | 1.35341643 |
| 46 | MP0009785_altered_susceptibility_to | 1.30301982 |
| 47 | MP0003303_peritoneal_inflammation | 1.29456943 |
| 48 | MP0001853_heart_inflammation | 1.26608006 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.26282490 |
| 50 | MP0005379_endocrine/exocrine_gland_phen | 1.24321663 |
| 51 | MP0003075_altered_response_to | 1.23404221 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.23017014 |
| 53 | MP0005671_abnormal_response_to | 1.22464117 |
| 54 | MP0001873_stomach_inflammation | 1.21101883 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.20160319 |
| 56 | MP0000490_abnormal_crypts_of | 1.15920810 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.14407496 |
| 58 | MP0000613_abnormal_salivary_gland | 1.14366185 |
| 59 | MP0002060_abnormal_skin_morphology | 1.14202283 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.14186551 |
| 61 | MP0001756_abnormal_urination | 1.13497218 |
| 62 | MP0003950_abnormal_plasma_membrane | 1.13212000 |
| 63 | MP0000609_abnormal_liver_physiology | 1.12905073 |
| 64 | MP0004858_abnormal_nervous_system | 1.11746121 |
| 65 | MP0005332_abnormal_amino_acid | 1.11119369 |
| 66 | MP0005025_abnormal_response_to | 1.10893999 |
| 67 | MP0001849_ear_inflammation | 1.10832030 |
| 68 | MP0001765_abnormal_ion_homeostasis | 1.10182033 |
| 69 | MP0009384_cardiac_valve_regurgitation | 1.10123386 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.08245191 |
| 71 | MP0001958_emphysema | 1.08191974 |
| 72 | MP0002933_joint_inflammation | 1.07428127 |
| 73 | MP0008469_abnormal_protein_level | 1.06466687 |
| 74 | MP0001790_abnormal_immune_system | 1.06123527 |
| 75 | MP0005387_immune_system_phenotype | 1.06123527 |
| 76 | MP0003448_altered_tumor_morphology | 1.05469947 |
| 77 | MP0001661_extended_life_span | 1.05361941 |
| 78 | MP0005165_increased_susceptibility_to | 1.04458209 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.04456348 |
| 80 | MP0009333_abnormal_splenocyte_physiolog | 1.03524280 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.03303852 |
| 82 | MP0002419_abnormal_innate_immunity | 1.02780497 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.01295177 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 1.01055969 |
| 85 | MP0004510_myositis | 0.98967599 |
| 86 | MP0002896_abnormal_bone_mineralization | 0.98668095 |
| 87 | MP0001542_abnormal_bone_strength | 0.96790873 |
| 88 | MP0005408_hypopigmentation | 0.96511663 |
| 89 | MP0000343_altered_response_to | 0.96337664 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.95776655 |
| 91 | MP0003693_abnormal_embryo_hatching | 0.95442243 |
| 92 | MP0003724_increased_susceptibility_to | 0.94730000 |
| 93 | MP0005375_adipose_tissue_phenotype | 0.93304127 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.93262281 |
| 95 | MP0003953_abnormal_hormone_level | 0.91361677 |
| 96 | MP0005310_abnormal_salivary_gland | 0.91326724 |
| 97 | MP0001800_abnormal_humoral_immune | 0.90945582 |
| 98 | MP0001764_abnormal_homeostasis | 0.90607610 |
| 99 | MP0003795_abnormal_bone_structure | 0.90239209 |
| 100 | MP0000604_amyloidosis | 0.89399287 |
| 101 | MP0009278_abnormal_bone_marrow | 0.89196174 |
| 102 | MP0001243_abnormal_dermal_layer | 0.88244661 |
| 103 | MP0005360_urolithiasis | 0.87974475 |
| 104 | MP0002723_abnormal_immune_serum | 0.87953802 |
| 105 | MP0005275_abnormal_skin_tensile | 0.87535938 |
| 106 | MP0001664_abnormal_digestion | 0.86523661 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.86458874 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.86031268 |
| 109 | MP0002089_abnormal_postnatal_growth/wei | 0.84807594 |
| 110 | MP0003763_abnormal_thymus_physiology | 0.84565569 |
| 111 | MP0004947_skin_inflammation | 0.84174100 |
| 112 | MP0004233_abnormal_muscle_weight | 0.84160250 |
| 113 | MP0001881_abnormal_mammary_gland | 0.83947216 |
| 114 | MP0005390_skeleton_phenotype | 0.83917744 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.82685193 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.82533131 |
| 117 | MP0000767_abnormal_smooth_muscle | 0.82008019 |
| 118 | MP0005257_abnormal_intraocular_pressure | 0.81861620 |
| 119 | MP0000598_abnormal_liver_morphology | 0.81604484 |
| 120 | MP0002254_reproductive_system_inflammat | 0.81581144 |
| 121 | MP0006082_CNS_inflammation | 0.80938606 |
| 122 | MP0003786_premature_aging | 0.79566290 |
| 123 | MP0002429_abnormal_blood_cell | 0.79382479 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.78967170 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.78360998 |
| 126 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78270472 |
| 127 | MP0002405_respiratory_system_inflammati | 0.78211952 |
| 128 | MP0000858_altered_metastatic_potential | 0.78178253 |
| 129 | MP0005330_cardiomyopathy | 0.77653739 |
| 130 | MP0005023_abnormal_wound_healing | 0.77548705 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.77464027 |
| 132 | MP0002452_abnormal_antigen_presenting | 0.76705308 |
| 133 | MP0005166_decreased_susceptibility_to | 0.76669763 |
| 134 | MP0001986_abnormal_taste_sensitivity | 0.76614842 |
| 135 | MP0003091_abnormal_cell_migration | 0.75857779 |
| 136 | MP0002420_abnormal_adaptive_immunity | 0.75813962 |
| 137 | MP0005164_abnormal_response_to | 0.75787244 |
| 138 | MP0003111_abnormal_nucleus_morphology | 0.75767579 |
| 139 | MP0001819_abnormal_immune_cell | 0.74768530 |
| 140 | MP0002398_abnormal_bone_marrow | 0.74602087 |
| 141 | MP0002269_muscular_atrophy | 0.74297503 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.74162837 |
| 143 | MP0002166_altered_tumor_susceptibility | 0.73856980 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.71971696 |
| 145 | MP0000358_abnormal_cell_content/ | 0.71955859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.08545063 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.67666978 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.64047632 |
| 4 | Symptomatic seizures (HP:0011145) | 4.41306216 |
| 5 | Premature rupture of membranes (HP:0001788) | 4.28834769 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.97225590 |
| 7 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.79354158 |
| 8 | Ketoacidosis (HP:0001993) | 3.78455334 |
| 9 | Generalized aminoaciduria (HP:0002909) | 3.76427808 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.74568318 |
| 11 | Late onset (HP:0003584) | 3.64579917 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.64170081 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.59868612 |
| 14 | Mucopolysacchariduria (HP:0008155) | 3.59868612 |
| 15 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.47302423 |
| 16 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.47302423 |
| 17 | Abnormal protein glycosylation (HP:0012346) | 3.47302423 |
| 18 | Abnormal glycosylation (HP:0012345) | 3.47302423 |
| 19 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.40223585 |
| 20 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.40223585 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.35744193 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.35744193 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.35744193 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32351265 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.31833056 |
| 26 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.28459841 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.27434796 |
| 28 | Ketosis (HP:0001946) | 3.25831388 |
| 29 | Abnormal gallbladder physiology (HP:0012438) | 3.25555264 |
| 30 | Cholecystitis (HP:0001082) | 3.25555264 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 3.09798406 |
| 32 | Hyperglycemia (HP:0003074) | 3.06690477 |
| 33 | Large for gestational age (HP:0001520) | 3.06264080 |
| 34 | Deep venous thrombosis (HP:0002625) | 3.04345576 |
| 35 | Insulin resistance (HP:0000855) | 2.72528563 |
| 36 | Achilles tendon contracture (HP:0001771) | 2.71045441 |
| 37 | Abnormality of the Achilles tendon (HP:0005109) | 2.69722234 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68862366 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68862366 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68862366 |
| 41 | Abdominal distention (HP:0003270) | 2.68766242 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61512725 |
| 43 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.60272753 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.59099648 |
| 45 | J-shaped sella turcica (HP:0002680) | 2.56523913 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.55986672 |
| 47 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.50975019 |
| 48 | Prolonged neonatal jaundice (HP:0006579) | 2.50757925 |
| 49 | Purpura (HP:0000979) | 2.49252292 |
| 50 | Protuberant abdomen (HP:0001538) | 2.48039308 |
| 51 | Biconcave vertebral bodies (HP:0004586) | 2.47046760 |
| 52 | Beaking of vertebral bodies (HP:0004568) | 2.45082094 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.43429494 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43429494 |
| 55 | Increased serum ferritin (HP:0003281) | 2.41308941 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39705371 |
| 57 | Cervical subluxation (HP:0003308) | 2.38158679 |
| 58 | Aplastic anemia (HP:0001915) | 2.37188855 |
| 59 | Thrombocytosis (HP:0001894) | 2.34678126 |
| 60 | Hyperparathyroidism (HP:0000843) | 2.34449571 |
| 61 | Gout (HP:0001997) | 2.32618041 |
| 62 | Nonimmune hydrops fetalis (HP:0001790) | 2.32587158 |
| 63 | Abnormality of complement system (HP:0005339) | 2.30743728 |
| 64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.29419161 |
| 65 | Progressive muscle weakness (HP:0003323) | 2.26729379 |
| 66 | Joint stiffness (HP:0001387) | 2.26503541 |
| 67 | Fragile skin (HP:0001030) | 2.26427917 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23471812 |
| 69 | Blue sclerae (HP:0000592) | 2.20547800 |
| 70 | Hemorrhage of the eye (HP:0011885) | 2.20419603 |
| 71 | Upper limb amyotrophy (HP:0009129) | 2.19413016 |
| 72 | Distal upper limb amyotrophy (HP:0007149) | 2.19413016 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.18378346 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.15544366 |
| 75 | Abnormal pancreas size (HP:0012094) | 2.14899904 |
| 76 | Xanthomatosis (HP:0000991) | 2.14791473 |
| 77 | Hypertensive crisis (HP:0100735) | 2.14421983 |
| 78 | Hepatic necrosis (HP:0002605) | 2.14094592 |
| 79 | Rough bone trabeculation (HP:0100670) | 2.13928703 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.13511471 |
| 81 | Myoglobinuria (HP:0002913) | 2.12499037 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12047461 |
| 83 | Loss of speech (HP:0002371) | 2.11544080 |
| 84 | Broad face (HP:0000283) | 2.08687049 |
| 85 | Complement deficiency (HP:0004431) | 2.08447084 |
| 86 | Myocardial infarction (HP:0001658) | 2.07248085 |
| 87 | Spondylolisthesis (HP:0003302) | 2.05963573 |
| 88 | Exocrine pancreatic insufficiency (HP:0001738) | 2.05163522 |
| 89 | Stridor (HP:0010307) | 2.04365065 |
| 90 | Retinal atrophy (HP:0001105) | 2.03140246 |
| 91 | Glomerulonephritis (HP:0000099) | 2.02777379 |
| 92 | Growth hormone excess (HP:0000845) | 2.01665631 |
| 93 | Petechiae (HP:0000967) | 2.00490164 |
| 94 | Elbow flexion contracture (HP:0002987) | 2.00343219 |
| 95 | Conjugated hyperbilirubinemia (HP:0002908) | 1.99956438 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 1.99937364 |
| 97 | Distal lower limb muscle weakness (HP:0009053) | 1.98529269 |
| 98 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97006407 |
| 99 | Axonal loss (HP:0003447) | 1.95021416 |
| 100 | Opisthotonus (HP:0002179) | 1.94233901 |
| 101 | Dilatation of the ascending aorta (HP:0005111) | 1.93223327 |
| 102 | Cortical visual impairment (HP:0100704) | 1.93019640 |
| 103 | Agitation (HP:0000713) | 1.92337944 |
| 104 | Hepatosplenomegaly (HP:0001433) | 1.91553927 |
| 105 | IgM deficiency (HP:0002850) | 1.91510119 |
| 106 | Malnutrition (HP:0004395) | 1.89540033 |
| 107 | Ankle contracture (HP:0006466) | 1.89532681 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.88557390 |
| 109 | Pancreatitis (HP:0001733) | 1.87590222 |
| 110 | Obstructive lung disease (HP:0006536) | 1.87489809 |
| 111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87489809 |
| 112 | Ragged-red muscle fibers (HP:0003200) | 1.87446653 |
| 113 | Mitral stenosis (HP:0001718) | 1.85997437 |
| 114 | Orchitis (HP:0100796) | 1.85849791 |
| 115 | Abnormality of carpal bone ossification (HP:0006257) | 1.85849044 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 1.85838619 |
| 117 | Emphysema (HP:0002097) | 1.85276834 |
| 118 | Atrophic scars (HP:0001075) | 1.83963012 |
| 119 | Poor head control (HP:0002421) | 1.83425268 |
| 120 | Bladder diverticulum (HP:0000015) | 1.83181828 |
| 121 | Abnormality of the acetabulum (HP:0003170) | 1.82724353 |
| 122 | Cardiovascular calcification (HP:0011915) | 1.82217694 |
| 123 | Thin bony cortex (HP:0002753) | 1.82005765 |
| 124 | Reticulocytosis (HP:0001923) | 1.81974809 |
| 125 | Entropion (HP:0000621) | 1.80458354 |
| 126 | Abnormality of dentin (HP:0010299) | 1.78848715 |
| 127 | Myositis (HP:0100614) | 1.78547718 |
| 128 | Hand muscle atrophy (HP:0009130) | 1.78512706 |
| 129 | Hypokinesia (HP:0002375) | 1.78193778 |
| 130 | Flat acetabular roof (HP:0003180) | 1.78112051 |
| 131 | Methylmalonic aciduria (HP:0012120) | 1.76414707 |
| 132 | Increased connective tissue (HP:0009025) | 1.76373823 |
| 133 | Thoracolumbar scoliosis (HP:0002944) | 1.76001633 |
| 134 | Cholelithiasis (HP:0001081) | 1.75184722 |
| 135 | Hypokalemia (HP:0002900) | 1.74745702 |
| 136 | Amyloidosis (HP:0011034) | 1.73747688 |
| 137 | Elevated alkaline phosphatase (HP:0003155) | 1.73432294 |
| 138 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72546490 |
| 139 | Generalized amyotrophy (HP:0003700) | 1.72287396 |
| 140 | Abnormal trabecular bone morphology (HP:0100671) | 1.72283931 |
| 141 | Abnormality of the costochondral junction (HP:0000919) | 1.71812653 |
| 142 | Vascular calcification (HP:0004934) | 1.71584147 |
| 143 | Peritonitis (HP:0002586) | 1.71398157 |
| 144 | Hypertriglyceridemia (HP:0002155) | 1.71109865 |
| 145 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.71010372 |
| 146 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70911360 |
| 147 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.70911360 |
| 148 | Trismus (HP:0000211) | 1.70904855 |
| 149 | Prominent metopic ridge (HP:0005487) | 1.69586819 |
| 150 | Asymmetric septal hypertrophy (HP:0001670) | 1.69014401 |
| 151 | Decreased subcutaneous fat (HP:0001002) | 1.68858559 |
| 152 | Fat malabsorption (HP:0002630) | 1.68762410 |
| 153 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68104308 |
| 154 | Palpitations (HP:0001962) | 1.67858767 |
| 155 | Skin nodule (HP:0200036) | 1.67143855 |
| 156 | Abnormal delivery (HP:0001787) | 1.66898281 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.65882170 |
| 158 | Irregular vertebral endplates (HP:0003301) | 1.65644536 |
| 159 | Abnormality of the anterior horn cell (HP:0006802) | 1.65505535 |
| 160 | Degeneration of anterior horn cells (HP:0002398) | 1.65505535 |
| 161 | Severe short stature (HP:0003510) | 1.65468006 |
| 162 | Joint hemorrhage (HP:0005261) | 1.65245389 |
| 163 | Myopathic facies (HP:0002058) | 1.65238137 |
| 164 | Abnormal tarsal ossification (HP:0008369) | 1.65182559 |
| 165 | Glucose intolerance (HP:0000833) | 1.65025221 |
| 166 | Cerebral aneurysm (HP:0004944) | 1.64752929 |
| 167 | Nuclear cataract (HP:0100018) | 1.63894692 |
| 168 | Wormian bones (HP:0002645) | 1.62517573 |
| 169 | Premature skin wrinkling (HP:0100678) | 1.61941906 |
| 170 | Aortic dissection (HP:0002647) | 1.61389964 |
| 171 | Polygenic inheritance (HP:0010982) | 1.60205181 |
| 172 | Short nail (HP:0001799) | 1.60183718 |
| 173 | Recurrent abscess formation (HP:0002722) | 1.59749360 |
| 174 | Spinal rigidity (HP:0003306) | 1.57017037 |
| 175 | Upper motor neuron abnormality (HP:0002127) | 1.56840111 |
| 176 | Distal lower limb amyotrophy (HP:0008944) | 1.55750587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.22856178 |
| 2 | BCKDK | 4.34376201 |
| 3 | FLT3 | 3.63950865 |
| 4 | INSRR | 3.35669870 |
| 5 | PASK | 2.96436527 |
| 6 | TRIB3 | 2.81130596 |
| 7 | TAOK3 | 2.68907410 |
| 8 | NME2 | 2.57936121 |
| 9 | MAPK15 | 2.53530240 |
| 10 | SMG1 | 2.52080947 |
| 11 | SCYL2 | 2.40923707 |
| 12 | IRAK3 | 2.38179614 |
| 13 | PIK3CG | 2.23246149 |
| 14 | TESK1 | 2.05197116 |
| 15 | MAP3K11 | 2.00743169 |
| 16 | ICK | 1.93432950 |
| 17 | PKN2 | 1.86141923 |
| 18 | EIF2AK3 | 1.83384839 |
| 19 | MAP2K2 | 1.70440492 |
| 20 | ZAP70 | 1.63807726 |
| 21 | MAPKAPK3 | 1.62684593 |
| 22 | JAK3 | 1.57815129 |
| 23 | TAOK2 | 1.56276079 |
| 24 | CAMKK2 | 1.49051360 |
| 25 | HIPK2 | 1.42468037 |
| 26 | MAP4K1 | 1.42102134 |
| 27 | PRPF4B | 1.40638766 |
| 28 | IRAK4 | 1.40450983 |
| 29 | PIM2 | 1.40298233 |
| 30 | TBK1 | 1.38322846 |
| 31 | DDR2 | 1.31584505 |
| 32 | STK16 | 1.31138103 |
| 33 | TYK2 | 1.24438999 |
| 34 | KIT | 1.24366247 |
| 35 | RIPK4 | 1.21688577 |
| 36 | PTK6 | 1.20405671 |
| 37 | TESK2 | 1.19301829 |
| 38 | MAP3K1 | 1.16409923 |
| 39 | SIK1 | 1.16185112 |
| 40 | MET | 1.14791046 |
| 41 | FRK | 1.12182386 |
| 42 | BTK | 1.10189285 |
| 43 | VRK2 | 1.09086629 |
| 44 | MAPK11 | 1.06803272 |
| 45 | ABL2 | 1.06269912 |
| 46 | MAP2K3 | 1.05064723 |
| 47 | EIF2AK1 | 1.03814245 |
| 48 | BUB1 | 1.03178872 |
| 49 | MAP3K2 | 1.02351882 |
| 50 | NME1 | 1.01651240 |
| 51 | MAP3K8 | 0.98752357 |
| 52 | WNK4 | 0.98207019 |
| 53 | FGFR4 | 0.97865687 |
| 54 | MAP3K12 | 0.95858927 |
| 55 | EEF2K | 0.95530965 |
| 56 | ARAF | 0.94487624 |
| 57 | NEK9 | 0.91069346 |
| 58 | CLK1 | 0.89630304 |
| 59 | MYLK | 0.87293064 |
| 60 | PTK2 | 0.86391885 |
| 61 | RPS6KB2 | 0.85315882 |
| 62 | DAPK1 | 0.77950611 |
| 63 | BMX | 0.77723098 |
| 64 | JAK1 | 0.77520513 |
| 65 | PRKD2 | 0.77396368 |
| 66 | PDGFRA | 0.77380415 |
| 67 | EPHB1 | 0.76583665 |
| 68 | IRAK1 | 0.76569920 |
| 69 | LRRK2 | 0.76521855 |
| 70 | PBK | 0.75116234 |
| 71 | DYRK1B | 0.73634942 |
| 72 | PRKD3 | 0.73608074 |
| 73 | BRAF | 0.71994151 |
| 74 | LMTK2 | 0.70659129 |
| 75 | MAP3K3 | 0.70462278 |
| 76 | KDR | 0.69538996 |
| 77 | EPHA2 | 0.68336379 |
| 78 | GRK6 | 0.68173458 |
| 79 | IKBKE | 0.66503881 |
| 80 | BRSK2 | 0.66144733 |
| 81 | EPHA3 | 0.66056191 |
| 82 | NTRK1 | 0.65559375 |
| 83 | TTN | 0.62980892 |
| 84 | RIPK1 | 0.62845167 |
| 85 | RPS6KA4 | 0.62447849 |
| 86 | CDK7 | 0.61377531 |
| 87 | PAK1 | 0.60475095 |
| 88 | PRKCI | 0.59654071 |
| 89 | PDPK1 | 0.59436303 |
| 90 | MAP3K13 | 0.59263182 |
| 91 | JAK2 | 0.58825670 |
| 92 | TEC | 0.58480023 |
| 93 | MATK | 0.54890130 |
| 94 | SYK | 0.54102956 |
| 95 | PAK4 | 0.52793175 |
| 96 | BRSK1 | 0.52541289 |
| 97 | MST1R | 0.51659043 |
| 98 | SIK3 | 0.50559368 |
| 99 | BLK | 0.49199802 |
| 100 | CSK | 0.49189830 |
| 101 | STK10 | 0.48106574 |
| 102 | PAK2 | 0.47962908 |
| 103 | AURKA | 0.46980239 |
| 104 | NLK | 0.45822532 |
| 105 | CSF1R | 0.44551364 |
| 106 | LYN | 0.43103144 |
| 107 | PRKCH | 0.42610504 |
| 108 | MAP2K1 | 0.42493210 |
| 109 | IKBKB | 0.42427295 |
| 110 | CDK4 | 0.40679513 |
| 111 | UHMK1 | 0.39609711 |
| 112 | PRKG2 | 0.39235522 |
| 113 | STK4 | 0.39207071 |
| 114 | TNK2 | 0.38668322 |
| 115 | ITK | 0.38527536 |
| 116 | LCK | 0.37962153 |
| 117 | MOS | 0.36942431 |
| 118 | CDC42BPA | 0.36919757 |
| 119 | PIK3CA | 0.35439134 |
| 120 | DAPK3 | 0.35068977 |
| 121 | LIMK1 | 0.34974263 |
| 122 | CHUK | 0.33767994 |
| 123 | MST4 | 0.33625197 |
| 124 | TGFBR1 | 0.32976941 |
| 125 | CDK8 | 0.31759250 |
| 126 | MAP3K6 | 0.31289285 |
| 127 | TGFBR2 | 0.31125132 |
| 128 | MAPKAPK2 | 0.31022125 |
| 129 | RPS6KA2 | 0.30477107 |
| 130 | TAOK1 | 0.30178456 |
| 131 | ILK | 0.29818439 |
| 132 | MAP3K14 | 0.29488970 |
| 133 | MTOR | 0.28497253 |
| 134 | PRKCD | 0.28437075 |
| 135 | ERBB3 | 0.27407630 |
| 136 | PDGFRB | 0.27240579 |
| 137 | MAP2K6 | 0.25605200 |
| 138 | KSR2 | 0.25425194 |
| 139 | PAK3 | 0.24544799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.57778085 |
| 2 | Protein export_Homo sapiens_hsa03060 | 6.30289763 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.63406756 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.36846277 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.94214902 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.66699566 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.40069781 |
| 8 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.09096689 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.06435855 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.01686003 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.96851544 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.87563376 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.83895123 |
| 14 | Galactose metabolism_Homo sapiens_hsa00052 | 1.77108303 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.73297916 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69581606 |
| 17 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.65101000 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61537895 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.39623985 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37927340 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.29277804 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27237325 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25619741 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24831232 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.23248625 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22088109 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.20458162 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15355433 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.11064472 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.09768037 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09652619 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06095265 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05643791 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01875546 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 0.98819415 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98731077 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.91997686 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 0.89840170 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89727810 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89421198 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 0.88736389 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87193813 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81879181 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 0.81055450 |
| 45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80343077 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 0.77895662 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77747517 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75892644 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74692796 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74018361 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71070122 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71036220 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.70922049 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70842416 |
| 55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70444865 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70312229 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.70287819 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70232967 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69963875 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68527313 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67778589 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67075845 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66376132 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65599815 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 0.64825987 |
| 66 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63959711 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63380228 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62922057 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62474988 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62022988 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60496617 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60269881 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58942566 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.57924305 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.56364613 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56190094 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56182819 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.56085300 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56054656 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55854694 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55624220 |
| 82 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55011209 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54501720 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.54271285 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54141544 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53565713 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.53544892 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52181206 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51995664 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50932046 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.50706622 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.49362418 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49117391 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48955059 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48361094 |
| 96 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47161379 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45494650 |
| 98 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44927790 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43728372 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43414188 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43376900 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.42865933 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42179351 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41630900 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41037522 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40738029 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39798494 |
| 108 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38514449 |
| 109 | Asthma_Homo sapiens_hsa05310 | 0.38347257 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.38188667 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38080814 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.37951767 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37376737 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.36966161 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35146442 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34641257 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34139378 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32564490 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32243085 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31427678 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29423233 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29049564 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.27663209 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27419673 |
| 125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27177951 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26735975 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26362177 |
| 128 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26355608 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.25966691 |
| 130 | Influenza A_Homo sapiens_hsa05164 | 0.25904247 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.25459297 |
| 132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24233882 |
| 133 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.24226503 |
| 134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22688227 |
| 135 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.18298983 |
| 136 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18008731 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17938142 |

